71 results
8-K
EX-1.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
such Regulatory Authorizations; (iv) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration … , action, suit, investigation or proceeding; (v) has not received notice that any of the Applicable Regulatory Authorities has taken, is taking
8-K
EX-1.1
STRO
Sutro Biopharma Inc
12 May 20
Entry into a Material Definitive Agreement
5:14pm
, hearing, enforcement, investigation, arbitration or other action from the Applicable Regulatory Authorities alleging that any product operation … is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (v) has not received notice that any
8-K
EX-1.1
STRO
Sutro Biopharma Inc
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
, hearing, enforcement, investigation, arbitration or other action from the Applicable Regulatory Authorities alleging that any product operation … is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (v) has not received notice that any of the Applicable
S-8
EX-5.1
STRO
Sutro Biopharma Inc
27 Feb 24
Registration of securities for employees
4:33pm
by the Company (the “Opinion Certificate”). We have not undertaken any independent investigation to verify the accuracy of any such information
8-K
EX-5.1
oqm083prpubiwe82
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-5.1
v98b4vz9dr ook1lw
9 Feb 24
Other Events
4:27pm
S-3MEF
EX-5.1
h6pdmh yzo96i3o
8 Dec 20
Registration of additional securities for an S-3
8:30pm
8-K
EX-99.1
wb1cqy928s3 psd2j6w9
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
S-3
EX-1.2
2zldmedbcz7rpaqvvq
4 Oct 19
Shelf registration
4:06pm
8-K
EX-99.1
9n53wrifmmt9 xwfes
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
EX-99.1
smnfilrs
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
EX-1.1
vhf6rz5t
9 Feb 24
Other Events
4:27pm
8-K
EX-99.1
qy78 uxyv7
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
S-3ASR
EX-1.2
ywuokct 93uwpz760
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-99.1
6140ndly ak
8 Nov 22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
EX-99.1
2j1g97j3 5gd
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm